GlassScriptPhysician profile
Patricia Quartin
NPI 1013314517
$3,804.67
in general payments reported to CMS, 2019-2025
18 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $944 · 2022: $2,105 · 2023: $229 · 2024: $344 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $890.34 | 2022-2025 | Sotyktu |
| Abbvie INC. | $616.39 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $336.82 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $329.12 | 2022 | |
| Sun Pharmaceutical Industries INC. | $316.25 | 2021-2022 | |
| Genentech USA, INC. | $270.94 | 2021 | |
| Leo Pharma INC. | $199.39 | 2021-2022 | |
| Almirall LLC | $151.08 | 2021 | |
| Galderma Laboratories, L.P. | $142.24 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $133.99 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $126.36 | 2021 | |
| Genzyme Corporation | $109.87 | 2022 | |
| Merz North America, INC. | $59.71 | 2022 | |
| Janssen Biotech, INC. | $48.87 | 2022 | |
| Amgen INC. | $21.23 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $19.92 | 2022 | |
| Journey Medical Corporation | $17.93 | 2022 | |
| Epi Health, LLC | $14.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Quartin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.